MicroPort Endovascular MedTech Ltd (688016) — Cash Flow Quality Index
MicroPort Endovascular MedTech Ltd (688016) has a Cash Flow Quality Index of 0.41x as of September 2025. Operating cash flow of CN¥46.79 Million is below net income of CN¥114.41 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of MicroPort Endovascular MedTech Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
MicroPort Endovascular MedTech Ltd Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for MicroPort Endovascular MedTech Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of MicroPort Endovascular MedTech Ltd.
Annual Cash Flow Quality Index for MicroPort Endovascular MedTech Ltd (2016–2025)
Year-by-year earnings quality comparison for MicroPort Endovascular MedTech Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.02x | CN¥573.06 Million | CN¥563.21 Million | ▲ +34.2% |
| 2024 | 0.76x | CN¥373.60 Million | CN¥492.75 Million | ▼ -34.6% |
| 2023 | 1.16x | CN¥571.22 Million | CN¥492.43 Million | ▲ +22.4% |
| 2022 | 0.95x | CN¥333.76 Million | CN¥352.05 Million | ▼ -1.0% |
| 2021 | 0.96x | CN¥300.25 Million | CN¥313.51 Million | ▼ -5.5% |
| 2020 | 1.01x | CN¥217.44 Million | CN¥214.61 Million | ▲ +0.3% |
| 2019 | 1.01x | CN¥143.20 Million | CN¥141.76 Million | ▼ -14.3% |
| 2018 | 1.18x | CN¥106.85 Million | CN¥90.65 Million | ▲ +7.7% |
| 2017 | 1.09x | CN¥69.36 Million | CN¥63.39 Million | ▲ +49.3% |
| 2016 | 0.73x | CN¥30.13 Million | CN¥41.11 Million | — |